Hg Capital Acquires Majority Stake in Intelerad: The Signify View

Written by Steve Holloway

Published: February 11, 2020

10th February 2020 – Written by Steve Holloway – Featured on Healthcare Business Euro News – After a relatively short search, Intelerad has found a new majority stakeholder, Hg Capital.  The London, UK-based investment firm has already invested over $1B in the healthcare and life sciences sector, including firms such as Rhapsody and Corepoint (healthcare data interoperability) , Allocate Software (healthcare workforce management), Evaluate (Pharmaceutical commercial information and advisory) and Medifox (ambulatory  are services). The deal is expected to close by the end of 1Q 2020, providing Intelerad with a substantial new investor and war chest. So what will Intelerad do with the new funds and what challenges lie ahead?

Click here to continue reading on Healthcare Business Euro News’ website… 

Related Report

Imaging IT – Market Intelligence Service – 2019/20

Ongoing series of reports, data and insights delivered over the year

Imaging IT – Market Intelligence Service – 2019/20

This Market Intelligence Service is an annual subscription that provides ongoing data, insights and analysis on the global opportunities for Imaging IT.

Find out more